Skip to main content
GLASGlass House Brands Inc. SubordiSell5.1·$9.79+2.84%
SellModerate Confidence
Investment thesis

GLAS is a small specialty-pharma name with no usable price feed this run, cash burn alongside declining revenue, and a bottom-decile peer ranking, offset only by a perfect 4-quarter earnings beat streak.

Thesis pillars

  • No Price Data Blocks Trade SetupStable
  • Cash Burning Declining RevenueStable
  • Perfect Earnings Beat StreakDeteriorating
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Glass House Brands Inc. Subordi (GLAS) Stock Analysis

Range Bound setup · Inst Constrain edge

SellVALUE-TRAP 1/5GrowthQualityShortModerate Confidence

Healthcare · Drug Manufacturers - Specialty & Generic

Sell if holding. Engine safety override at $9.79: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10 and A.R:R 3.4:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail... Read more

QualityF-score5 / 9FCF yield-2.83%
Stop $9.10Target $13.60(analyst − 15%)A.R:R 3.4:1
Analyst target$16.00+63.4%3 analysts
$13.60our TP
$9.79price
$16.00mean
$17

Sell if holding. Engine safety override at $9.79: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10 and A.R:R 3.4:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: RSI 47 mid-range, Bollinger mid-band. Score 5.1/10, moderate confidence.

Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 81d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-08-23

Recent Developments — Glass House Brands Inc. Subordi

Generated 2026-08-23T02:21:54Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Nov 11, 202681d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (2.2 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)43.5
Mkt Cap$923M
EV/EBITDA-96.9
Profit Mgn-20.7%
ROE-20.4%
Rev Growth-9.6%
Beta0.64
DividendNone
Rating analysts12

Quality Signals

Piotroski F5/9

Options Flow

P/C1.00neutral
IV81%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Unprofitable operations — net margin -20.7%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Net Margin
0.0
Fcf Quality
0.0
Gross Margin
3.5
Moat
4.0
Piotroski F
5.6
Current Ratio
6.5
Cash-burning: FCF -15% of revenueNo competitive moatQuality concerns

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
0.7
Quality Rank
1.8
Value Rank
1.9
GatesMomentum 5.7>=5.5A.R:R 3.4 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 81d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
47 · Neutral
20D MA 50D MA 200D MASupport $9.12Resistance $10.59

Price Targets

$9
$14
A.Upside+38.9%
A.R:R3.4:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (2.2 < 4.0)

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-11-11 (81d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is GLAS stock a buy right now?

Sell if holding. Engine safety override at $9.79: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10 and A.R:R 3.4:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: RSI 47 mid-range, Bollinger mid-band. Prior stop was $9.10. Score 5.1/10, moderate confidence.

What is the GLAS stock price target?

Take-profit target: $13.60 (+38.9% upside). Prior stop was $9.10. Stop-loss: $9.10.

What are the risks of investing in GLAS?

Quality below floor (2.2 < 4.0).

Is GLAS overvalued or undervalued?

Glass House Brands Inc. Subordi trades at a P/E of N/A (forward 43.5). TrendMatrix value score: 7.0/10. Verdict: Sell.

What do analysts say about GLAS?

12 analysts cover GLAS with a consensus score of 4.2/5. Average price target: $16.

What does Glass House Brands Inc. Subordi do?Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United...

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services. The Wholesale Biomass segment includes propagation, nursery, flowering canopy, dries, processes, and distributes cannabis biomass. The Cannabis-Related Consumer Packaged Goods segment manufactures, extracts, infuse, conversion, packaging, and distributes cannabis products. The company cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. It also offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company serves its cannabis products under the Glass House Farms, PLUS, Allswell, REEFORM, and Mama Sue brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.

Related stocks: IRWD (Ironwood Pharmaceuticals, Inc.) · BCRX (BioCryst Pharmaceuticals, Inc.) · ANIP (ANI Pharmaceuticals, Inc.) · EOLS (Evolus, Inc. Common Stock) · KNSA (Kiniksa Pharmaceuticals Interna)
Home Stocks GLAS

Latest news

Latest News

Benzinga9d ago
Benzinga9d agoEarnings
Benzinga39d ago
Benzinga40d ago
Benzinga47d agoProduct